Brazilian drugmaker Hypera's talks with rivals not currently active, source says (updated)

Ems Chemie Holding AG

06/07/2022 14:36

(Adds Hypera, Group NC statements)
    By Tatiana Bautzer
    SAO PAULO, July 6 (Reuters) - Brazilian pharmaceutical
company Hypera has discussed a takeover offer from rival company
NC Group, the owner of EMS SA, but talks are not currently
active, one source with knowledge of the matter said on
Wednesday. 
    Hypera has also discussed a sale to local pharmaceutical
company Eurofarma, the source added.
    Hypera's controlling shareholder, Joao Alves de Queiroz
Filho, has a 21% stake in the company and a shareholder
agreement with Mexican holding Maiorem SA de CV owns another
15%. 
    Hypera, in a statement, denied that it was in talks with
rivals. Eurofarma did not immediately respond to requests for
comment. In a statement, Group NC denied "any negotiation" with
Hypera.
    The source said that talks with NC Group were halted three
months ago and are not currently active. The talks with
Eurofarma had taken place earlier and also are not currently
active, the source said. Shares in Hypera  HYPE3.SA  were up
5.4% at 39.61 reais in early trading in Sao Paulo. They have
sharply outperformed the benchmark Ibovespa this year.
    The talks were first reported by Brazilian newspaper Valor
Economico, citing sources with knowledge of the
matter. urn:newsml:reuters.com:*:nL1N2YMEK3

 (Reporting by Tatiana Bautzer; Editing by Louise Heavens and
Paul Simao)
 ((tatiana.bautzer@tr.com; Tel: +55-11-5644-7756; Mob:
+55-119-4210-4173; Reuters Messaging:
tatiana.bautzer.thomsonreuters.com@reuters.net))